pyrazines has been researched along with Skin Ulcer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billet, A; Chaby, G; Chatelain, D; Christophe, O; Dadban, A; Damaj, G; Lenglet, A; Lok, C; Marolleau, JP; Royer, R; Thuillier, D; Vaida, I; Viseux, V | 1 |
| Heule, F; Lam, K; Sonneveld, P; Wu, KL | 1 |
| MacDonald, JR; Pegg, DG | 1 |
3 other study(ies) available for pyrazines and Skin Ulcer
| Article | Year |
|---|---|
[Bortezomib-induced eruption: Sweet syndrome? Two case reports].
Topics: Antineoplastic Agents; Biopsy; Boronic Acids; Bortezomib; Colchicine; Dexamethasone; Female; Humans; Leukemia, Plasma Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Pyrazines; Skin Ulcer; Sweet Syndrome; Treatment Outcome | 2009 |
Pleomorphic presentation of cutaneous lesions associated with the proteasome inhibitor bortezomib in patients with multiple myeloma.
Topics: Adult; Aged; Boronic Acids; Bortezomib; Drug Eruptions; Drug Therapy, Combination; Erythema; Fever; Glucocorticoids; Histamine H1 Antagonists; Humans; Male; Medical Records; Middle Aged; Multiple Myeloma; Prednisone; Protease Inhibitors; Pyrazines; Skin; Skin Ulcer | 2006 |
Extravasation injury potential of CI-980, a novel synthetic mitotic inhibitor.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Carbamates; Depression, Chemical; Extravasation of Diagnostic and Therapeutic Materials; Injections, Intradermal; Irritants; Male; Mice; Mice, Inbred BALB C; Mitosis; Pyrazines; Pyridines; Skin Ulcer; Vinblastine | 1993 |